Aurobindo Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406A01037
  • NSEID: AUROPHARMA
  • BSEID: 524804
INR
1,686.10
44.1 (2.69%)
BSENSE

Oct 09

BSE+NSE Vol: 7.12 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 164981,
    "name": "Aurobindo Pharma",
    "stock_name": "Aurobindo Pharma",
    "full_name": "Aurobindo Pharma Ltd.",
    "name_url": "stocks-analysis/aurobindo-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,686.10",
    "chg": 44.1,
    "chgp": "2.69%",
    "dir": 1,
    "prev_price": "1,642.00",
    "mcapval": "94,604.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 524804,
    "symbol": "AUROPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE406A01037",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "7.12 lacs",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/aurobindo-pharma-164981-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Pharma Stocks Gain Momentum: Lupin, Aurobindo Pharma, Medanta & Apollo In Focus",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-10-01 16:31:24",
        "description": "Pharma Stocks Gain Momentum: Lupin, Aurobindo Pharma, Medanta & Apollo In Focus  Business Today..."
      },
      {
        "title": "Pharma Stocks Gain Momentum: Lupin, Aurobindo Pharma, Medanta & Apollo In Focus",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-10-01 16:31:24",
        "description": "Pharma Stocks Gain Momentum: Lupin, Aurobindo Pharma, Medanta & Apollo In Focus  Business Today..."
      },
      {
        "title": "Aurobindo Pharma Limited",
        "link": "https://news.google.com/rss/articles/CBMiaEFVX3lxTE5QdzlfdUJKUXBuOVBDdmVxNWdsTDZGdVNudU9HalB1b1lzdVFKbUw4RHMtV1k0OFdzN2gydTVFdHl6UDFhbHRZT0c1ZjN2bElMbktHbDJKN094VG5lWjBOWWxiTEk1NjBo?oc=5",
        "imagepath": "",
        "date": "2026-10-01 10:06:35",
        "description": "Aurobindo Pharma Limited  Reuters..."
      },
      {
        "title": "GST appellate authority upholds 4.6 crore ITC claim order against Aurobindo Pharma",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-30 08:34:49",
        "description": "GST appellate authority upholds 4.6 crore ITC claim order against Aurobindo Pharma  thehindubusinessline.com..."
      },
      {
        "title": "Sun Pharma, Aurobindo Pharma, other stocks in focus as Trump exempts India from 100% tariffs on some speci",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-29 08:56:22",
        "description": "Sun Pharma, Aurobindo Pharma, other stocks in focus as Trump exempts India from 100% tariffs on some speci  The Economic Times..."
      },
      {
        "title": "JM Financial sees up to 28% upside in Dr Reddys and Aurobindo Pharma. Should you buy?",
        "link": "https://news.google.com/rss/articles/CBMi-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?oc=5",
        "imagepath": "",
        "date": "2026-09-16 14:39:55",
        "description": "JM Financial sees up to 28% upside in Dr Reddys and Aurobindo Pharma. Should you buy?  The Economic Times..."
      },
      {
        "title": "Aurobindo Pharma gets USFDA approval for generic inhalation aerosol for asthma patients",
        "link": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxQcU02Vlh0R1AtaEZXWU92ZW9iLTRReUhmczB3YWo5ckI4ZW1Yenpiajc0YUFMSmRwQ01LZlQ0bFIxeXE5dktCdFloLUZWbXBkM2RvdUQ4WW5wTUxNYWdVLTI3WDhJN3pXcVQtTWhaMDJoY09NMHFRZjRGTE92bzd1dkZlaS1KX1g0SllLc2ZqemxWbFlvTmllYWxlQnh0eENkUTBPOFBJdEhON0liNEcwQlRrUmNiVFQxT3NKVENJeHhVLVJXNl9SVEpQY3NzOWZuSC1EN3FySldCTGE4UmFVZG5VWEsxMTk2TmfSAfABQVVfeXFMTVVKRVNkWFc2elp3VFNWbjFvSzI1TG9BaW0xZDllZXlrSDY3Q1lIYUU2RHhVVlZrLVV6U0VGakdKOVN3SHJpX3Uya1VkbGxqVzJlbFJXSnhodWtaNmkweXM3M0NOY1huMTBPQU5mVW9LWWxtTTI1V1FKT0tMRUYyRVNQRlgtZ0RVXzBiaTFPd0FGX0ViZDN4T3VNekpMaXM2SUt1dlFEbFVLMUM2S3FJSkR3STg1YUV6WWZ3MnZ1Ulo1YW1oRHZ2TzdUYXpyYnFjUzZmUndvTTJSbnVzb2tQR1BaeG13UjdNeEZxWXNLRTF4?oc=5",
        "imagepath": "",
        "date": "2026-09-15 16:06:01",
        "description": "Aurobindo Pharma gets USFDA approval for generic inhalation aerosol for asthma patients  BusinessLine..."
      },
      {
        "title": "Aurobindo Pharma gets USFDA approval for generic inhalation aerosol for asthma patients",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-15 16:06:01",
        "description": "Aurobindo Pharma gets USFDA approval for generic inhalation aerosol for asthma patients  BusinessLine..."
      },
      {
        "title": "Aurobindo Pharma gets USFDA approval for first metered-dose inhaler",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-15 15:37:25",
        "description": "Aurobindo Pharma gets USFDA approval for first metered-dose inhaler  financialexpress.com..."
      }
    ],
    "total": 13,
    "sid": "164981",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/aurobindo-pharma-164981"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "05-Oct-2026",
      "details": "Submission of certificate in terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended September 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "03-Oct-2026",
      "details": "Submission of Press Release that is being issued by the Company in connection with receipt of USFDA final approval for Perampanel Tablets 2 mg 4 mg 6 mg 8 mg 10 mg and 12 mg.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015.",
      "datetime": "02-Oct-2026",
      "details": "Intimation of completion of acquisition.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has declared <strong>400%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has announced <strong>1:5</strong> stock split, ex-date: 10 Feb 11",
          "dt": "2011-02-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 20 Jul 15",
          "dt": "2015-07-20",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

05-Oct-2026 | Source : BSE

Submission of certificate in terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended September 30 2026.

Announcement under Regulation 30 (LODR)-Press Release / Media Release

03-Oct-2026 | Source : BSE

Submission of Press Release that is being issued by the Company in connection with receipt of USFDA final approval for Perampanel Tablets 2 mg 4 mg 6 mg 8 mg 10 mg and 12 mg.

Disclosure Under Regulation 30 Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015.

02-Oct-2026 | Source : BSE

Intimation of completion of acquisition.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Aurobindo Pharma Ltd. has declared 400% dividend, ex-date: 08 Aug 25

stock-summary
SPLITS

Aurobindo Pharma Ltd. has announced 1:5 stock split, ex-date: 10 Feb 11

stock-summary
BONUS

Aurobindo Pharma Ltd. has announced 1:1 bonus issue, ex-date: 20 Jul 15

stock-summary
RIGHTS

No Rights history available